Target Price | CNY199.41 |
Price | CNY256.68 |
Deviation |
22.31%
register free of charge
|
Number of Estimates | 26 |
26 Analysts have issued a price target BeOne Medicines 2026 .
The average BeOne Medicines target price is CNY199.41.
This is
22.31%
register free of charge
CNY295.00
14.93%
register free of charge
CNY155.05
39.59%
register free of charge
|
|
A rating was issued by 30 analysts: 29 Analysts recommend BeOne Medicines to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the BeOne Medicines stock has an average upside potential 2026 of
22.31%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion CNY | 27.21 | 36.77 |
56.19% | 35.12% | |
EBITDA Margin | -13.43% | 5.77% |
72.09% | 142.95% |
32 Analysts have issued a sales forecast BeOne Medicines 2025 . The average BeOne Medicines sales estimate is
This results in the following potential growth metrics:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CNY | -3.64 | 0.88 |
26.46% | 124.18% | |
P/E | 289.42 |
13 Analysts have issued a BeOne Medicines forecast for earnings per share. The average BeOne Medicines EPS is
This results in the following potential growth metrics and future valuations:
BeOne Medicines...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.